Tirzepatide — Coming Soon

Tirzepatide is a synthetic dual incretin receptor agonist studied for its activity at both GLP-1 and GIP receptors. Research focuses on its effects on receptor signaling pathways, glucose metabolism, insulin secretion dynamics, and energy balance in controlled in vitro and preclinical models.

Disclaimer
This product is intended for laboratory research use only and is not for human or veterinary use.